Merrion Investment Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.76M Hold
7,000
0.83% 28
2026
Q1
$1.52M Hold
7,000
0.82% 30
2025
Q4
$1.6M Hold
7,000
0.86% 29
2025
Q3
$1.62M Hold
7,000
0.93% 25
2025
Q2
$1.3M Hold
7,000
0.84% 30
2025
Q1
$1.47M Hold
7,000
1.05% 25
2024
Q4
$1.24M Hold
7,000
0.87% 24
2024
Q3
$1.38M Buy
7,000
+500
+8% +$93.3K 0.91% 25
2024
Q2
$1.11M Hold
6,500
0.77% 29
2024
Q1
$1.18M Hold
6,500
0.85% 28
2023
Q4
$1.01M Hold
6,500
0.79% 30
2023
Q3
$969K Hold
6,500
0.84% 27
2023
Q2
$876K Hold
6,500
0.74% 29
2023
Q1
$1.04M Hold
6,500
0.99% 22
2022
Q4
$1.05M Hold
6,500
0.98% 25
2022
Q3
$872K Hold
6,500
0.86% 26
2022
Q2
$996K Hold
6,500
0.96% 23
2022
Q1
$1.05M Sell
6,500
-1,100
-14% -$160K 0.77% 28
2021
Q4
$1.03M Hold
7,600
0.75% 28
2021
Q3
$819K Sell
7,600
-4,400
-37% -$503K 0.62% 34
2021
Q2
$1.35M Hold
12,000
1.02% 22
2021
Q1
$1.3M Hold
12,000
1.08% 22
2020
Q4
$1.29M Buy
+12,000
New +$1.15M 1.09% 21

Other funds holding ABBV

Merrion Investment Management's ABBV Position: Q2 2026 in Review

Merrion Investment Management held its AbbVie (ABBV) position steady in Q2 2026 at 7,000 shares worth $1.76M. The position accounts for 0.83% of the portfolio, ranked #28.

Merrion Investment Management first reported a position in ABBV in Q4 2020 and has held it in 23 quarters since. 1,758 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Merrion Investment Management held 7,000 shares of AbbVie worth $1.76M as of Q2 2026.
  • Merrion Investment Management left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 0.83% of Merrion Investment Management's portfolio in Q2 2026, its #28 holding.
  • Merrion Investment Management first reported a position in AbbVie in Q4 2020 and has held it in 23 quarters since.
  • 1,758 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Merrion Investment Management's 13F filing for Q2 2026, filed 13 Jul 2026.